There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Most patients with opioid addiction do not receive medication at the time of discharge
from brief inpatient detoxification programs despite the high risk of relapse and
the availability of three FDA-approved medications. We surveyed 164 inpatient opioid
detoxification patients to assess desire for pharmacotherapy following detoxification
program discharge. Participants were predominantly male (71.3%) and 80% had detoxed
in the past. Reporting on their most recent previous inpatient detoxification, 27%
had relapsed the day they were discharged, 65% within a month of discharge, and 90%
within a year of discharge. 63% reported they wanted medication-assisted treatment
(MAT) after discharge from the current admission. The odds of desiring a treatment
medication increased by a factor of 1.02 for every 1% increase in perceived relapse
risk (p<.01). These data suggest patient preference discussions including relapse
risk could increase post-detox abstinence.